Cargando…
The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
BACKGROUND: Better treatment during early stages of chronic kidney disease (CKD) may slow progression to end-stage renal disease and decrease associated complications and medical costs. Achieving early treatment of CKD is challenging, however, because a large fraction of persons with CKD are unaware...
Autores principales: | Yarnoff, Benjamin O., Hoerger, Thomas J., Simpson, Siobhan K., Leib, Alyssa, Burrows, Nilka R., Shrestha, Sundar S., Pavkov, Meda E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347833/ https://www.ncbi.nlm.nih.gov/pubmed/28288579 http://dx.doi.org/10.1186/s12882-017-0497-6 |
Ejemplares similares
-
The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease
por: Yarnoff, Benjamin O., et al.
Publicado: (2016) -
Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study
por: Yarnoff, Benjamin O., et al.
Publicado: (2018) -
Reported Cases of End-Stage Kidney Disease — United States, 2000–2019
por: Burrows, Nilka Ríos, et al.
Publicado: (2022) -
Trends in Hospitalizations for Acute Kidney Injury — United States, 2000–2014
por: Pavkov, Meda E., et al.
Publicado: (2018) -
The relation between dialysis-requiring acute kidney injury and recovery from end-stage renal disease: a national study
por: Chen, Zijin, et al.
Publicado: (2019)